These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 10918348)
1. The sensitivity to change over time of the Bristol Activities of Daily Living Scale in Alzheimer's disease. Byrne LM; Wilson PM; Bucks RS; Hughes AO; Wilcock GK Int J Geriatr Psychiatry; 2000 Jul; 15(7):656-61. PubMed ID: 10918348 [TBL] [Abstract][Full Text] [Related]
3. A naturalistic study of galantamine for Alzheimer's disease. Brodaty H; Woodward M; Boundy K; Barnes N; Allen G; CNS Drugs; 2006; 20(11):935-43. PubMed ID: 17044730 [TBL] [Abstract][Full Text] [Related]
4. The Empirical Behavioral Pathology in Alzheimer's Disease (E-BEHAVE-AD) Rating Scale. Auer SR; Monteiro IM; Reisberg B Int Psychogeriatr; 1996; 8(2):247-66. PubMed ID: 8994895 [TBL] [Abstract][Full Text] [Related]
5. Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease. Gauthier S; Lopez OL; Waldemar G; Jones RW; Cummings J; Zhang R; Schindler R; Schwam E Int Psychogeriatr; 2010 Sep; 22(6):973-83. PubMed ID: 20534179 [TBL] [Abstract][Full Text] [Related]
6. Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Bucks RS; Ashworth DL; Wilcock GK; Siegfried K Age Ageing; 1996 Mar; 25(2):113-20. PubMed ID: 8670538 [TBL] [Abstract][Full Text] [Related]
7. Global measures: utility in defining and measuring treatment response in dementia. Reisberg B Int Psychogeriatr; 2007 Jun; 19(3):421-56. PubMed ID: 17480241 [TBL] [Abstract][Full Text] [Related]
8. Long-Term Efficacy of Galantamine in Alzheimer's Disease: The Okayama Galantamine Study (OGS). Nakano Y; Matsuzono K; Yamashita T; Ohta Y; Hishikawa N; Sato K; Deguchi K; Abe K J Alzheimers Dis; 2015; 47(3):609-17. PubMed ID: 26401696 [TBL] [Abstract][Full Text] [Related]
9. [Planning and activities of daily living in Alzheimer's disease and frontotemporal dementia]. Piquard A; Derouesné C; Lacomblez L; Siéroff E Psychol Neuropsychiatr Vieil; 2004 Jun; 2(2):147-56. PubMed ID: 15683978 [TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. Davis KL; Thal LJ; Gamzu ER; Davis CS; Woolson RF; Gracon SI; Drachman DA; Schneider LS; Whitehouse PJ; Hoover TM N Engl J Med; 1992 Oct; 327(18):1253-9. PubMed ID: 1406817 [TBL] [Abstract][Full Text] [Related]
11. The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group. Raskind MA; Cyrus PA; Ruzicka BB; Gulanski BI J Clin Psychiatry; 1999 May; 60(5):318-25. PubMed ID: 10362441 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden. Feldman H; Gauthier S; Hecker J; Vellas B; Emir B; Mastey V; Subbiah P; J Am Geriatr Soc; 2003 Jun; 51(6):737-44. PubMed ID: 12757558 [TBL] [Abstract][Full Text] [Related]
13. A comparison of the Cohen-Mansfield agitation inventory with the CERAD behavioral rating scale for dementia in community-dwelling persons with Alzheimer's disease. Weiner MF; Koss E; Patterson M; Jin S; Teri L; Thomas R; Thal LJ; Whitehouse P J Psychiatr Res; 1998; 32(6):347-51. PubMed ID: 9844950 [TBL] [Abstract][Full Text] [Related]
14. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study. Rocca P; Marino F; Montemagni C; Perrone D; Bogetto F Psychiatry Clin Neurosci; 2007 Dec; 61(6):622-9. PubMed ID: 18081622 [TBL] [Abstract][Full Text] [Related]
16. Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial. Rockwood K; Mintzer J; Truyen L; Wessel T; Wilkinson D J Neurol Neurosurg Psychiatry; 2001 Nov; 71(5):589-95. PubMed ID: 11606667 [TBL] [Abstract][Full Text] [Related]
17. The Lawton Instrumental Activities Daily Living/Activities Daily Living Scales: A Sensitive Test to Alzheimer Disease in Community-Dwelling Elderly People? Koskas P; Henry-Feugeas MC; Feugeas JP; Poissonnet A; Pons-Peyneau C; Wolmark Y; Drunat O J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):85-93. PubMed ID: 24578460 [TBL] [Abstract][Full Text] [Related]
18. Clinical utility of the functional independence measure for assessment of patients with Alzheimer's disease and vascular dementia. Tanaka N; Nakatsuka M; Ishii H; Nakayama R; Hosaka R; Meguro K Psychogeriatrics; 2013 Dec; 13(4):199-205. PubMed ID: 24289460 [TBL] [Abstract][Full Text] [Related]
19. Awareness of disease is different for cognitive and functional aspects in mild Alzheimer's disease: a one-year observation study. Sousa MF; Santos RL; Nogueira ML; Belfort T; Rosa RD; Torres B; Simões P; Mograbi DC; Laks J; Dourado MC J Alzheimers Dis; 2015; 43(3):905-13. PubMed ID: 25125460 [TBL] [Abstract][Full Text] [Related]
20. Bayer-activities of daily living scale in mild and moderate dementia of the Alzheimer type. Nagaratnam N; Nagaratnam K; O'Mara D Am J Alzheimers Dis Other Demen; 2013 Dec; 28(8):784-9. PubMed ID: 24005851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]